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Results of international correlation and migrant studies suggest that dietary fat promotes
carcinogenesis in hormone-sensitive sites, but this is disputed. In the present study, we used
a Noble rat model of sex hormone-induced cancers to examine the effect of a high-fat diet
on the incidence and latency of prostate and mammary cancer in male (n 139) and female (n
72) animals respectively. We also measured a-tocopherol levels in female breast tissue to
determine whether a high intake of polyunsaturated fatty acids depletes antioxidant defence
in target tissues, providing a possible potentiating mechanism for carcinogenesis. Results
showed a very high incidence of hormone-induced adenocarcinomas of prostate and mammary
gland, irrespective of diet. There was no difference in the pattern of carcinogenesis in different
prostatic locations, weight of the prostate, or weight gain between male rats on the high-fat diet
compared with the control (standard, low-fat) diet. In female rats, the incidence of mammary
cancer and the body-weight gain were the same in both dietary groups, and breast a-tocopherol
was also unaffected by dietary fat intake. Our present results are supportive of recent cohort
studies that reported no significant association between intake of fat and the development of
human prostate and breast cancer, and do not support a role for dietary fat in promoting sex
hormone-induced prostate and mammary carcinogenesis.
Noble rats: Prostate cancer: Breast cancer: Carcinogenesis: Dietary fat: Vitamin E
The global incidence of cancer is increasing both absol-
utely and in relation to other diseases, and the incidence
is projected to rise from 10·3 million cases in 1996 to
14·7 million in 2020 (World Cancer Research Fund/
American Institute for Cancer Research, 1997). In western
countries, prostate cancer and breast cancer are a major
public health concern. These are the two most common
cancers and are second only to lung cancer as a cause of
cancer mortality among American men and women
respectively (Jemal et al. 2002).
There are significant differences in breast- and prostate-
cancer incidence and mortality rates in different parts of
the world (Rose et al. 1986; Landis et al. 1999). Compared
with the USA, the incidence and age-adjusted mortality
rates of both breast and prostate cancer are up to 10-fold
lower in Asian countries (Hursting et al. 1990; Whittemore
et al. 1995; Zock, 2001). In Asian groups who have
migrated to the USA, however, prostate- and breast-
cancer rates tend to increase rapidly and immigrants
acquire the cancer risk profiles of the host country
(Parkin et al. 1993; Angwafo, 1998). The changing pattern
of risk that occurs after migration from, usually, a country
of low risk to one of high risk supports the concept that
most human cancers arise not just from simple inherited
predispositions, but also by interaction with the environ-
ment. Further, as inhabitants of Asian countries adapt
western-style diets, the incidence of prostate and breast
cancers increases (Haenszel & Kurihara, 1968). Results
from population and migrant studies have led to the general
belief that diet, particularly with reference to intake of fat,
is an important determinant of common cancers such as
breast and prostate cancer. The National Academy of
Sciences report on diet, nutrition and cancer in 1982 and
the subsequent report on diet and health in 1989
(Committee on Diet, Nutrition, and Cancer, National
Research Council, 1982; Committee on Diet and Health,
National Research Council, 1989) both concluded there
was a causal relationship between dietary fat and cancer.
However, this has been disputed recently in the World
Cancer Research Fund reports (World Cancer Research
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studies of experimental carcinogenesis using rat models
have produced controversial views on the link between
prostate cancer and consumption of a high-fat (HF) diet
(Pollard & Luckert, 1986; Carroll & Noble, 1987; Pour
et al. 1991; Takai, 1991; Kondo et al. 1994). Most
experiments in male rats have resulted in only a small
number of cases of prostate cancer in animals fed a HF
diet. Furthermore, dietary studies on female rats and
mice have generally used chemical carcinogens, usually
1,2-dimethylbenz(a)anthracene or N-methylnitrosourea
(Freedman et al. 1990; Clarke, 1997) to induce mammary
tumourigenesis. A useful alternative approach to the study
of carcinogenic influences on sex-hormone-related cancers
is the Noble rat model, first used by Noble and his
colleagues (Noble, 1976, 1977). Our laboratory has
established a modified approach, using a higher dosage
of testosterone and 17b-oestradiol, to give a high incidence
of prostate and mammary cancer in a shorter period of time,
and have used this model successfully in prostate- (Wang &
Wong, 1998; Wong et al. 1998; Tam et al. 2000; Wong
& Wang, 2000; Wong et al. 2000; Xie et al. 2000b,c;
Ouyang et al. 2001) and breast- (Xie et al. 1999a,b,c,d,
2000a; Leung et al. 2002) cancer studies. We consider
sex-hormone induction in Noble rats an appropriate
model, as carcinoma of both prostate and breast are sex-
hormone related, and this model can induce a high inci-
dence of both types of tumours. Moreover, the growth
patterns and histopathology of the tumours induced in the
Noble rat model have a high resemblance to the features
of their counterpart in human subjects (Wang & Wong,
1998; Xie et al. 1999b )
In the present study, we evaluated the effect of a HF diet
on prostate and mammary tumour development burden,
using the Noble rat model of sex-hormone-induced
cancer. Maize oil, a cooking oil commonly consumed
by western populations, was used as the source of dietary
fat for the animals. This has a high content of the n-6
polyunsaturated fatty acid linoleic acid (Escrich et al.
1994). It has been suggested that eicosanoids formed
from linoleic acid by lipoxygenase action have a key role
in breast-cancer growth, invasion and metastasis (Rose
et al. 1991) and on prostate-cancer cell growth in vitro
(Rose & Connolly, 1991). Furthermore, it has been
proposed (Bartsch et al. 1999) that peroxidation of con-
jugated double bonds in polyunsaturated fatty acids (such
as linoleic acid), leads to persistent oxidative stress and
generation of reactive lipid peroxidation products that
can induce DNA damage and contribute towards carcino-
genesis (Vaca et al. 1988; Chung et al. 1996). Many anti-
oxidants, such as the lipophilic a-tocopherol have been
considered protective against cancer (Statland, 1992). In
the present study, therefore, we also investigated the con-
centration of a-tocopherol (vitamin E) in the breast tissue
of female Noble rats treated with sex hormones for 4
months. Our working hypothesis with regard to this part
of the present study was that high intake of polyunsaturated
fatty acids would deplete antioxidant defence in the target
tissue and that this, in turn, would have a promoting effect
on breast cancer, potentiating the effect of eicosanoids and
oxidative stress. The serum concentration of testosterone
and oestradiol were also measured at regular intervals to
see if there was any dietary influence on the metabolism
of these hormones, as it has also been suggested that a
HF diet may increase the concentration of free fatty acids
in serum and, in turn, displace oestrogen from serum
albumin, making it free for uptake by oestrogen receptors
(Bartsch et al. 1999).
Materials and methods
Diets
Rodent Laboratory Diet (PMI Feeds Inc., St Louis, MO,
USA) was used as the standard low-fat (LF) diet and the
HF diet was prepared by adding Mazolaw maize oil
(CPC International Inc., Englewood Cliffs, NJ, USA) to
the standard diet to give an additional fat content of
200 g/kg. Thus, the total fat content of the LF diet was
45 g/kg as stated by the supplier, and that of the HF
diet was 245 g/kg. The HF diet was prepared once per
week and stored at 48C until used. According to the
producer (CPC International Inc.) the fat content of
Mazolaw maize oil is (g/100 g total fat): saturated fat
14·3, polyunsaturated fat 57·1, monounsaturated fat 24·6.
Hormones
Capsules of powdered testosterone as testosterone propio-
nate (Sigma, St Louis, MO, USA) and 17b-oestradiol
(Fluka, Buchs, Switzerland) were prepared by hand-
packing, separately, medical grade silastic tubing (no.
602–305 tubing, internal diameter 1·54 mm, external
diameter 3·18 mm; Dow-Corning Corporation, Midland,
MI, USA) and sealing this with medical silicone adhesive
(RTV-108; General Electric, Waterford, NY, USA). Each
2 cm capsule contained 30 mg testosterone and each
1·0 cm capsule 22 mg 17b-oestradiol. Empty capsules
were prepared for the control rats.
Animal models
Male and female Noble rats, weaned and aged 1 month,
were housed separately and randomly divided into two
dietary (LF and HF) groups. One group was fed with HF
diet (the experimental group) and the other with LF diet
for the next 2 months. At 3 months of age, the (now)
sexually mature Noble rats were implanted, under sterile
conditions, with capsules (either containing hormone, or
empty capsules for hormone control rats) in the sub-
cutaneous space between the scapulae. Male rats were
implanted with six testosterone capsules and one
17b-oestradiol capsule and female rats were implanted
with two testosterone capsules and one 17b-oestradiol
capsule. Age- and sex-matched rats in each of the two
dietary groups were implanted with empty capsules. All
capsules were replaced at 12-week intervals and all rats
were allowed to have food and water ad libitum and
housed under controlled conditions (12 h light–dark
cycle, 22 ^ 28C). The body weight of each rat was
recorded once per week. Male rats from each group
were killed by cervical dislocation at 3, 4, 6, 8, 10
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months after implantation and examined for the appear-
ance and progress of prostate tumours. Female rats in
each group were palpated regularly for mammary
tumours, starting from 2 months after the capsules were
implanted. Rats were killed when the palpated tumour
masses exceeded 2 cm in diameter or when the animals
became moribund. All remaining female rats were killed
12 months after hormone implantation. At the end of
the experimental period, 211 rats had been investigated:
108 (males n 72, females n 36) received the HF diet;
103 (males n 67, females n 36) received the LF diet.
With regard to hormone treatment, 139 of these rats
(males n 91, females n 48) received hormones, and sev-
enty-two rats (males n 48, females n 24) did not. At the
end of the experimental period, the animals were killed
by cervical dislocation.
To measure the concentration of a-tocopherol in the
breast tissue, another four groups of female rats (following
the protocol as described earlier) were kept for 4 months
before killing, and the breast tissue excised and extracted.
There were forty rats in this group, twenty on each diet;
thirty-two rats received hormone treatment and eight did
not.
Based on results from male rats, a follow-up study was
performed in which fifty additional male rats were
implanted with half the dose of testosterone (i.e. 90 mg
testosterone) and fed HF (n 25) or LF (n 25) diets. Apart
from the smaller dose of testosterone, all other aspects of
this follow-up study, including the dose of 17b-oestradiol,
were the same as in the main study.
Autopsy and pathological examination
The prostate glands were excised, the dorsal, lateral and
ventral lobes were dissected out, and the wet weight of
the whole prostate and individual lobes were recorded
before they were fixed in buffered formalin (100 ml/l),
processed and embedded into paraffin wax. Paraffin
sections of 4mm were prepared, stained with haematoxylin
resin and examined by bright-field microscopy. Mammary
glands and any tumours were removed and fixed in neutral
buffered formalin and similarly processed and stained with
haematoxylin and eosin. Histopathology of prostate glands
was based on the criteria and classification outlined
previously (Wang & Wong, 1998; Wong et al. 1998) and
that of the mammary glands were based on the criteria
and classification of breast pathology outlined by Rosen
(1997).
Measurement of testosterone and oestradiol in serum
Blood samples were collected once per month from the
tail of a subsample of animals in each subgroup (n 6) to
evaluate the circulatory sex hormone levels. Serum was
collected and stored at 2208C. At the time of killing,
heart blood of the animals was also collected. The
serum testosterone concentration was determined by an
ELISA method (EIAgen Testosterone kit; BioChem
ImmunoSystems, Rome, Italy). The serum oestradiol con-
centration was measured by an ELISA (VIDAS Oestradiol
II Kit and mini VIDAS instrument; BioMerieux Vitek,
Marcy L’Etoile, France).
a-Tocopherol analysis on breast tissues
Preparation of the tissue for analysis was performed
according to method of Sheehy et al. (1994). At killing,
the thoracic mammary glands of the female rats were
dissected and snap frozen with liquid N2 and stored at
2808C before the extraction process. All visible fat and
any loose connective tissue were trimmed away. A
homogenate of breast tissue (200 g/l KCl (11·5 g/l) was
prepared. A sample of homogenate (1 ml) was transferred
into a 10 ml screw-capped Pyrex tube fitted with a
Teflon-lined cap. A duplicate sample was spiked with
1 ml dl-a-tocopherol standard (50mg/ml ethanol). Freshly
prepared pyrogallol (2 ml; 10 ml/l ethanol) was added to
each tube. Homogenates were saponified in a water-bath
at 708C for 30 min and then cooled on ice. After addition
of l ml distilled water and 4 ml hexane (with 0·05 ml
butylated hydroxytoluene/l), the tubes were vortexed
thoroughly and centrifuged at 2500 rpm for 10 min. The
upper hexane layer was removed and the homogenate
was re-extracted with 2 ml hexane (with 0·05 ml butylated
hydroxytoluene/l) prior to analysis. DL-a-Tocopherol
(980–1020 g/kg) and toluene were purchased from Merck
(Darmstadt, Germany), absolute ethanol and hexane were
from Riedel-de Haen (Seelze, Germany), butylated
hydroxytoluene was from Sigma and methanol (HiperSolv
for HPLC) was from BDH Laboratory Supplies (Poole,
Dorset, UK).
HPLC analysis
The chromatography system comprised an Alliance 2690
Separations Module with temperature-controlled column
chamber and autosampler (Waters, Milford, MA, USA),
Waters 996 Photodiode Array Detector and Waters
Millennium 32 PDA software (version 3.05.01), a
reverse-phase C18 analytical column (5mm, 250 £ 5 mm
internal diameter; Isco Inc., Lincoln, NE, USA) and a
cartridge guard column (Spherisorb C18, 5mm, cartridge
10 £ 5 mm internal diameter; Isco Inc.). The mobile
phase was methanol–toluene (80: 20, v/v), which was
filtered and degassed through a Millipore membrane (type
GV, pore size 0·22mm; Millipore Corp., Bedford, MA,
USA) before use. The detection was set at 292 nm and the
flow rate was 1·0 ml/min. The column worked at room tem-
perature, but the cooling chamber of the autosampler was set
at 48C. Freshly prepared calibrators (10, 20, 30 and 40mmol
a-tocopherol/l ethanol) were used to construct the calibration
curve. The calibrators were temporarily stored in an ice-
bath and protected from light during preparation. Once pre-
pared, 100ml of each calibrator were transferred into a
small glass vial fitted with a micro-glass insert and the
vial was placed inside the autosampler at 48C. Each cali-
brator (20ml) was injected into the HPLC system.
Measurement of sample extracts and calculations
Each of the sample extracts in 200ml ethanol as described
earlier was diluted ten times in ethanol and 20ml diluted
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extract was injected into the column. The peak area of
a-tocopherol was used as the variable for determination.
From the slope of the standard curve, the concentration
(mmol/l) of a-tocopherol in each diluted sample extract
was calculated simply by the peak area of sample over
the slope of the calibration curve, and the result was
dilution-corrected and expressed as mmol/l for direct
comparison of tissue extracts.
Statistical analysis
Comparison of body weight and wet weight of target tissue
between groups was by one-way ANOVA. Differences in
incidence of carcinoma in different sites in the different
groups and subgroups were tested by x2 and Fisher’s
exact test. Significance at P,0·05 was sought.
Results
Prostatic carcinogenesis in male Noble rats
Male rats were killed at different time points (3, 4, 6, 8, 10
months) to determine the incidence, mass and different
stages of prostatic carcinogenesis. At autopsy, the prostate
gland of hormone-treated animals showed gross enlarge-
ment and the wet weights of the prostate gland of these
animals were significantly (P,0·05) greater than those of
the animals receiving no hormone. However, there was
no significant difference detected in the weight of the
prostate glands between the experimental and control
dietary groups (Fig. 1).
Histological examination of the prostate glands of the
hormone-treated male rats showed pre-malignant and
malignant changes, whereas no such changes were seen
Fig. 1. Effect of a high- or low-fat diet on the weight of the prostate
gland of male Noble rats at 6 months post implantation of
capsules containing 180 mg testosterone propionate and 22 mg
17b-oestradiol or empty control capsules (capsules were replaced
at 12-week intervals). For details of diets and procedures, see
p. 400. Values are means with their standard errors represented
by vertical bars. a,b Mean values with unlike superscript letters
were significantly different (one-way ANOVA, P,0·05). T
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in the rats receiving no hormone treatment, regardless of
diet. In the male rats treated with the high dosage of
hormone (180 mg testosterone and 22 mg 17b-oestradiol),
after 6 months of hormone treatment there was an
incidence of adenocarcinoma of nearly 100 % in the peri-
urethral prostate in the hormone-treated rats, irrespective
of the type of diet (Table 1). Tumours were mostly well
differentiated and arose from the peri-urethral ducts of
the dorsal and lateral prostate (Fig. 2(a)). It was also appar-
ent that the tumours tended to spread into the ducts of the
lateral lobe and from there into the stroma of the lateral
lobe (Fig. 2(b and c)). In the lateral lobe, glandular dys-
plastic lesions were common with increasing incidence of
carcinoma noted with duration of treatment (Fig. 2(c)). In
the ventral lobe, glandular hyperplastic and dysplastic
lesions were more frequently observed. Carcinoma of the
ventral lobe was present in 20–30 % of animals treated
for 10 months, but these tumours were mostly in focal
areas at the periphery of the lobe (Fig. 2(d)). There were
no tumours arising from the dorsal lobe. All prostatic
tumours identified were organ-confined without metastasis
to other organs within the experimental period. In the
follow-up study using the smaller dose of testosterone
(90 mg testosterone and 22 mg 17b-oestradiol), a similar
pattern was seen except that the tumours developed more
slowly and there was a lower incidence of adenocarcinoma
of the peri-urethral prostate (Table 2). No significant
difference (P.0·05) was found in the incidence of
prostatic carcinoma, dysplasia and hyperplasia in the
different locations between the two dietary groups at
different periods of induction, irrespective of the dose of
testosterone. None of the animals not receiving hormone
treatment showed any prostate tumourigenesis.
The body weight of the four subgroups of male rats
showed no significant difference before hormone treatment
(Fig. 3). The body weight of the animals treated with
hormones in both diet groups showed an initial decline
after 1 month, after which body weight remained constant.
There was no significant difference in the body weight of
the hormone-treated animals in the HF and LF groups at
different time points. The animals given no hormone
gained weight steadily, and these animals were signifi-
cantly heavier than the hormone-treated animals at all
time points from 1 month after implantation. In addition,
there was significantly (P,0·05) greater weight gain
shown by the HF dietary group receiving no hormone
treatment at all time points after 2 months. In the
hormone-treated rats, circulatory testosterone levels
increased 5–30-fold and serum oestradiol levels increased
3–9-fold compared with age- and diet-matched controls.
There was no significant difference in the serum hormone
levels between the HF and LF groups (results not shown).
Mammary carcinogenesis of female Noble rats
No tumours developed in the rats not treated with
hormones, irrespective of diet. In the rats receiving
hormone treatment, palpable mammary tumour masses
first appeared at 5 months post implantation in both
experimental dietary groups. Cumulative incidences of
mammary carcinoma in the two groups were 79 and
63 % in the HF- and LF-diet groups respectively (Fig. 4),
Fig. 2. Histopathology of prostate carcinogenesis in male Noble rats post implantation of
180 mg testosterone propionate and 22 mg 17b-oestradiol (capsules were replaced at
12-week intervals). (a) well-differentiated adenocarcinoma arising from the peri-urethral
ducts in the prostatic urethra ( ˆ ); (b) spreading of cancer cells along the ducts towards
the lateral lobe ( ˆ ); (c) irregular acinar cells nests invading into the stroma of the lateral
lobe ( ˆ ); (d) foci of carcinoma at the periphery of the ventral lobe. j—j, 20mm. For details
of diets and procedures, see p. 400.
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with a slight but non-significant difference between the
two experimental groups (P.0·05). Latency periods of
tumourigenesis in both experimental groups were similar
(Table 3). The mean number of tumour masses per
hormone-treated female rat overall were 1·42 and 1·27 in
the HF- and LF-diet groups respectively. The mammary
tumours induced in both experimental dietary groups
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Fig. 3. Effects of a high-fat (W, X) or low-fat (e, O) diets on the
body weight of male Noble rats post implantation of capsules
containing 180 mg testosterone propionate and 22 mg 17b-oestra-
diol (X, e) or empty control capsules (W, O) (capsules were
replaced at 12-week intervals). For details of diets and procedures,
see p. 400. Mean value for the body weight of hormone-treated
rats fed on the high-fat diet was not significantly different from
that of the low-fat group (P.0·05). The mean body weight of the
untreated control groups was significantly greater than that of the
hormone-treated groups (P,0·05).
Fig. 4. Cumulative incidence of development of mammary tumours
in female Noble rats fed on low-fat (O) or high-fat (W) diets post
implantation of capsules containing 60 mg testosterone propionate
and 22 mg 17b-oestradiol (capsules were replaced at 12-week
intervals). For details of diets and procedures, see p. 400. Palpable
mammary tumour masses first appeared at 5 months post
implantation in both groups. Cumulative incidences of mammary
carcinoma in the two groups were 79 and 63 % for low-fat and high-
fat groups respectively. The mean values for tumour incidence and
latency period in the high-fat group were not significantly different
from those of the low-fat group. None of the animals in the
untreated control groups developed tumours within 12 months
(results from normal controls not shown in figure).
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were largely ductal carcinomas of papillary, cribriform,
comedo and solid types (Fig. 5), ranging from 8–35 mm
in diameter at the time of autopsy. Extraductal invasions
were common although no evidence of metastasis was
found within the experimental period.
The body weight of the four subgroups of female rats
showed no significant difference before hormone treat-
ment (Fig. 6). Unlike the male rats, the female Noble
rats had a gradual increase in body weight with hormone
treatment. Starting from the fifth month, the weight of the
hormone-treated animals on HF diet was slightly, but non-
significantly, higher than the matching LF group. The
body weights of the animals not receiving hormone
were significantly greater than the corresponding hor-
mone-treated animals at all time points after 3 months
(P,0·05). In the HF female rats, after hormone implan-
tation serum testosterone levels increased 10–100-fold
and oestradiol levels increased 4–5-fold compared with
age- and diet-matched controls. No significant difference
was seen in the hormone levels between the two
experimental groups (results not shown).
a-Tocopherol analysis in breast tissue
Mean recovery of a-tocopherol in the spike samples was
90 %, which was considered good. The a-tocopherol
concentration in the breast tissue extracts is shown in
Table 4. There was no effect of diet, as no significant
difference was seen in the tissue a-tocopherol level
between the hormone-controlled subgroups. However, the
Table 3. Induction of mammary tumours in Noble rats fed on high-fat or low-fat
diets for 12 months*
Rats with
tumour
Latency period
(months)
Group Diet and treatment n n % Mean SD
1 High-fat hormone treated† 24 19 79 8·68 2·15
2 Low-fat, hormone treated† 24 15 63 8·60 2·15
3 High-fat untreated‡ 12 0 0 0
4 Low-fat untreated‡ 12 0 0 0
* For details of diets and procedures, see p. 400.
† Capsules containing testosterone propionate (60 mg) + 17b-oestradiol benzoate (22 mg)
were implanted and replaced at 12-week intervals.
‡ Empty capsules were implanted.
Fig. 5. Histopathology of mammary gland carcinogenesis in female Noble rats post
implantation of 180 mg testosterone propionate and 22 mg 17b-oestradiol. (a) papillary
pattern (papillary fronds are covered by hyperchromatic nuclei); (b) cribriform pattern
(round or oval microlumina with smooth edges bordered by neoplastic cells; note the inva-
sion of tumour cells into the stroma on the right ( ˆ )); (c) solid pattern (the ductal lumen is
totally obliterated by the proliferation of irregularly shaped nests of closely aggregated cells);
(d) comedo pattern (central necrosis surrounded by bands of tumour cells). j—j, 20mm. For
details of diets and procedures, see p. 400.
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a-tocopherol levels in the breast tissue of hormone-treated
animals were significantly (P,0·05) higher than those of
the animals that did not receive hormone treatment.
Discussion
Prostate carcinogenesis
In the present study, a high incidence of prostate cancer
was seen in male Noble rats (the set with higher dosage
of hormone) within a relatively short period of time of
hormone treatment, confirming the efficiency of the
animal model and its usefulness for study of prostate
cancer. Analysis of the different stages of carcinogenesis
in the three different locations of the prostate (peri-urethral
region, lateral and ventral lobes) at various induction
periods showed similar incidences in both the LF- and
HF-diet groups. This indicates that dietary fat has no
influence per se on sex hormone-induced prostatic carcino-
genesis. However, it is possible that the system was already
maximally stimulated by the hormones, so that additional
dietary intervention would not have any effect. To test
this, we performed a follow-up study (as described on
p. 401) in which male rats were implanted with half the
dose of testosterone. Prostatic carcinoma developed more
slowly with the lower hormonal stimulation, but results
again showed no significant difference in the incidence
of tumour development between the two diet groups.
This is further indication that dietary fat itself does not
promote carcinogenesis.
The growth of the male rats treated with sex hormones
and fed with HF or standard (LF) diets was similar
throughout the experimental period, indicating that there
was no significant difference in energy intake and utilization
balance between these two groups. Being the target organs
of testosterone influence, the size and weight of the prostate
glands were much higher in hormone-treated animals.
However, the lack of difference in prostate mass between
the two dietary groups indicates that the influence of
these additional hormones on the weight of the prostate
gland and on the body as a whole was not affected by
the fat content of diet. The HF and LF diets were not iso-
energetic, as reported by others (Donato, 1987); however,
the results suggest that the energy intake was similar in
each dietary group. This supports the view that a high
energy intake from an HF diet, rather than dietary fat
itself, increases the risk of cancer (Ip, 1993).
There are a number of epidemiological and case studies
of dietary influences on prostatic carcinogenesis (Blair &
Fraumeni, 1978; Kolonel et al. 1981; Graham et al.
1983; Rose et al. 1986; Hursting et al. 1990; Bravo et al.
1991; West et al. 1991; Pienta & Esper, 1993). However,
due to the lack of suitable animal models, there have
been limited in vivo studies in this important area. Most
recent laboratory research has been done on prostate
cancer cell lines and transgenic mouse models, which are
less comparable with the human situation (Rose &
Connolly, 1991; Wang et al. 1995; Pandalai et al. 1996;
Aronson et al. 1999). Our present animal model closely
mimics the different stages of prostatic carcinogenesis in
human subjects, from pre-malignant to fully developed
adenocarcinoma with different degrees of differentiation,
although, in this current study, all the prostatic carcinomas
induced were organ-confined and had not reached the stage
equivalent to a clinically advanced, metastatic stage in
human subjects. Nonetheless, the model is similar to the
situation in human subjects, where there is a higher
incidence of latent or micro-focal carcinoma of the prostate
than advanced stage carcinoma. In human subjects, the
incidence of latent carcinoma is relatively constant and
unrelated to race, geography and difference in diet
(Breslow et al. 1977; Sakr et al. 1993). It has been
reported, however, that there is an association between
high dietary fat intake and the risk of having advanced
Fig. 6. Effects of a high-fat (W, X) or low-fat (K, O) diets on the
body weight of female Noble rats post implantation of capsules con-
taining 60 mg testosterone propionate and 22 mg 17b-oestradiol
(X, K) or empty control capsules (W, O) (capsules were replaced at
12-week intervals). For details of diets and procedures, see p. 400.
The mean body weight of hormone-treated rats fed on the high-fat
diet was not significantly different from that of the low-fat group
(P.0·05). The mean body weight of both untreated control groups
was significantly greater than that of the corresponding hormone-
treated groups after 3 months (P,0·01). The mean body weight of
rats fed on the high-fat diet was significantly different from that of
the low-fat group after 7 months (P,0·05).
Table 4. Level of a-tocopherol in the mammary tissue of Noble rats
fed on high-fat or low-fat diets for 4 months*†
(Mean values and standard deviations)
Group Diet and treatment n
a-Tocopherol
level (mM)‡
Mean SD
1 High-fat, hormone-treated§ 16 400a 96
2 Low-fat, hormone-treated§ 16 414a 159
3 High-fat, untreatedk 4 297b 59
4 Low-fat, untreatedk 4 287b 47
a,b Mean values within a column with unlike superscript letters were
significantly different (P,0·05).
* For details of diets and procedures, see p. 400.
† There was no significant difference in the levels of tissue a-tocopherol
between the two hormone-treated groups or that of the two untreated
control groups.
‡ All samples measured represent the same mass of tissue.
§ Capsules containing testosterone propionate (60 mg) + 17b-oestradiol
benzoate (22 mg) were implanted and replaced at 12-week intervals.
kEmpty capsules were implanted.
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stage disease (Giovannucci et al. 1993). In our present
model, tumour incidence was almost 100 % after hormone
treatment for 6 months; however, the HF diet did not effect
the promotion of these cancers to an advanced stage within
the experimental period.
Mammary carcinogenesis
In the current study, a very high incidence of mammary
cancer was induced within 12 months of hormone treat-
ment in both diet groups. The histopathological pattern of
tumours induced and the mode of invasion were similar
to that of the naturally occurring human breast cancer.
The incidence and number of tumours developed per rat
were slightly higher in the HF-diet group, but the dif-
ference was not statistically significant. The latency and
pattern of tumour development were also similar in the
two dietary groups. The results indicate that dietary fat
has little influence on sex hormone-induced mammary
carcinogenesis of the female Noble rat model. This is in
general agreement with the results of Carroll & Noble
(1987), who used only oestrone, a more toxic form of
oestrogen, for mammary carcinoma induction in Noble
rats. In the past decades, it has been shown consistently
that mice and rats fed HF diets develop mammary tumours
more readily than control animals on LF diets when chemi-
cal carcinogens are used to induce carcinogenesis (Carroll
& Khor, 1970; Chan & Dao, 1981; Tang et al. 1996). The
difference between the ability of HF diets to enhance
chemical-induced, but not hormone-induced, mammary
carcinogenesis in female rats cannot be explained, but it
might be a consequence of the different characteristics of
the different models used. For example, in most situations,
virgin rats were given a dose of chemical carcinogen at a
young age (35–60 d) when the mammary gland is
exquisitely susceptible to tumour induction. In our present
model, hormone induction was applied to sexually mature
rats and sustained throughout the experimental period by
the slow diffusion of hormones from the silastic capsules.
Furthermore, as commented by Ip (1993), in previous
studies on experimental models of fat intake and mammary
cancer, HF intake promotes mammary carcinogenesis only
under a very stringent set of conditions, and these might
not be duplicated in the setting of fat intake and human
breast-cancer risk. Since the reports of the Committee on
Diet, Nutrition, and Cancer, National Research Council
(1982) and the Committee on Diet and Health, National
Research Council (1989), much research on the diet and
breast cancers has been done. The hypothesis that dietary
fat plays a role in breast cancer has undergone much
scientific controversy and debate. Further, in epidemio-
logical studies linking fat intake and breast cancer, there
are other factors, such as differences in lifestyle, repro-
ductive history, eating habits, as well as complexity of
the total diet which must be considered. This could be
the reason why the positive association in international
comparisons, the epidemiological evidence of a strong,
positive correlation between dietary fat and breast cancer,
and the results of most other animal experiments, are not
supported by large cohort studies of human breast cancer
(Holmes et al. 1999).
Our results from analysis of a-tocopherol (vitamin E) in
breast tissues showed a similar level in animals in both
dietary groups. These results do not support the hypothesis
that peroxidation of conjugated double bonds in poly-
unsaturated fatty acids leads to persistent oxidative stress,
causing depletion of antioxidant defence in the target
tissue and indirectly contributing to carcinogenesis
(Bartsch, 1999). It is interesting to note, however, that
a-tocopherol levels of hormone-treated rats were con-
sistently higher in both dietary groups than the untreated
animals, given that maize oil contains high levels of
a-tocopherol. This may suggest that the sex hormones
have either caused an increase in the antioxidant level in
the target organ, or have a role against its depletion from
the tissue. With regard to the first possibility, vitamin E
may accumulate in actively dividing tissue, and could
possibly be found at higher concentration in proliferating
tissue in a malignant or pre-malignant stage (Halliwell &
Gutteridge, 1999). With regard to the second possibility,
oestrogens have antioxidant, as well as carcinogenic,
properties. It is possible, therefore, that oestrogen can
spare or recycle a-tocopherol. However, the resulting oxi-
dized form of oestrogen may damage DNA (Liehr, 1997),
thereby increasing cancer risk in the face of apparently
adequate antioxidant defence. It has also been proposed
that dietary fat increases breast-cancer risk by raising
blood oestrogen levels (Wu et al. 1999); however, our
present results showed that there was no difference in
oestrogen levels between the HF- and LF-diet groups,
whether treated with hormones or not. This is in agreement
with finding of the comparative study of blood concen-
trations of oestradiol among pre-menopausal Japanese
and Caucasian women with different dietary habits
(Moore et al. 1991).
Prostate and breast cancers have a great deal in common
apart from their high incidence rates and lifetime risks. The
organs involved are both under the influences of steroid
hormones and related growth factors, and removal of
gonads reduces tumour incidences in both sexes (Lopez-
Otin & Diamandis, 1998). Our present animal model,
which uses sex hormones, is considered to be highly
relevant for the study of these two homologous cancers
in males and females. The current study has shown that
an HF diet has no influence on the tumour incidence,
latency or type in regard to prostate and mammary cancers
induced by sex hormones in Noble rats. Therefore, the
long-standing belief that a HF diet promotes the develop-
ment of these two cancers is not supported by our present
results. Furthermore, our results are consistent with the
1997 report from the World Cancer Research Fund
(World Cancer Research Fund/American Institute for
Cancer Research, 1997) and the Working Group of the
UK Committee on Medical Aspects of Food and Nutrition
Policy (COMA) 1998, which concluded that the evidence
that dietary fat increases cancer risk is not strong. Our find-
ings are also in agreement with two recently published,
large-cohort studies (Holmes et al. 1999; Schuurman et al.
1999). In the large (n 58 279) prospective analysis on
prostate cancer, Schuurman et al. (1999) concluded that
there was no association between prostate carcinoma and
intake of energy, total fat, total saturated fatty acids or
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total trans unsaturated fatty acids. In the other study, a pro-
spective cohort dietary study of 88 795 women followed up
for 14 years, Holmes et al. (1999) concluded that there was
no evidence that a lower intake of total fat or of specific
types of fat reduces the risk of breast cancer.
In conclusion, this current study, using the Nobel rat
model, lends experimental support to the view that dietary
fat has no direct influence on either prostate or mammary
carcinogenesis. Furthermore, the good agreement seen
between the results of this experimental study using the
hormone-induced Noble rat model and the results of
large human cohort studies of prostate and breast cancer
endorses the usefulness of the present animal model in
study of human cancers related to sex hormones. This
validated model will facilitate the study of dietary
influences, molecular mechanisms of aetiology, control
and prevention of these common and often fatal cancers.
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